MMHG values genuine partnerships with consumers to deliver the best outcomes for individuals. We recognise that people with lived experience of mental health services and carers hold vital knowledge about what is needed from the system, both for individual care and at broader organisational levels. MMHG is committed to meaningful partnerships with consumers and carers to support the development and delivery of more effective and efficient services and research.
Tabs are an effective way to organize information on a website page when there is a large amount of content that needs to be separated into distinct categories. Label your tabs with one or two words that define each category of information.
When styling your tabs, highlight the selected tab by giving it a color that differs from your unselected tabs, so that it's easy for your visitors to navigate.
Brain Stimulation Trials
Our brain stimulation research program aims to explore the clinical development and optimisation of non-invasive brain stimulation therapies. These include:
Brain Stimulation Trials and Depression
We are conducting a series of clinical trials aim to optimise the application of transcranial magnetic stimulation in the treatment of people diagnosed with treatment resistant major depressive disorder.
These trials are run through our clinical TMS program. Participants will be recruited through referrals from treating clinicians and from patients presenting for TMS therapy to the clinics of Monarch Mental Health Group. Participants eligible for the research trials will receive a standard depression TMS treatment plus a potential additional element.
Brain Stimulation Trials and Obsessive-Compulsive Disorder
We are also carrying out a clinical trial exploring the efficacy of a home-based, individualised application of transcranial alternating current stimulation (tACS). You may be eligible to take part in this study if you are aged between 18-65 years old and have a diagnosis of OCD.
Our psychedelic research program aims to explore the clinical application of psychedelic assisted therapy.
These trials include investigating:
The efficacy, safety and tolerability of psychedelic assisted therapy for people living with a diagnosis of:
Obsessive-compulsive disorder
Treatment resistant major depressive disorder
Post-traumatic stress disorder
The psychological, cognitive and physiological changes associated with a single session of psychedelic drug exposure with psilocybin or MDMA in a group setting:
This study is a non-clinical study, recruiting individuals who have completed psychedelic assisted psychotherapy training [recruitment is now closed].
Our Strategy
How we are Achieving These Objectives
We welcome and value feedback from individuals who use MMHG services. Feedback is obtained through multiple methods including individual interviews, surveys and focus groups and this feedback is used for service delivery improvement.
We have established a consumer working group to guide our consumer participation strategy and ensure that we are involving and collaborating with consumers in and about all aspects of the organisation
We are in the process of establishing a consumer advisory board to collaborate in service development and design.
We are in the process of establishing a consumer advisory board to collaborate in service development and design.
We conduct consumer focus groups to consult on individual projects.
We welcome and value feedback from individuals who use MMHG services. Feedback is obtained through multiple methods including individual interviews, surveys and focus groups and this feedback is used for service delivery improvement.